查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511923

勝任細胞市場規模、佔有率、趨勢分析報告：按類型、應用、最終用途、地區和細分市場預測，2024-2030 年

Competent Cells Market Size, Share & Trends Analysis Report By Type, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

勝任細胞市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球勝任細胞市場規模將達35.9億美元，2024年至2030年複合年成長率為8.10%。

生物製藥研究的增加、基因編輯技術的進步以及合成生物學領域的擴展預計將推動市場成長。此外，生物技術和製藥產業嚴重依賴勝任細胞來生產重組蛋白、酵素和疫苗。治療、研究和工業應用對這些產品的需求不斷成長，推動了對勝任細胞的需求。

COVID-19 大流行大大促進了勝任細胞市場的發展。感受態細胞的需求量很大，因為它們對於分子克隆、基因工程和重組蛋白製造等任務至關重要，並且在疫苗製造、診斷測試和治療研究中發揮關鍵作用。鑑於生產疫苗和治療 COVID-19 的迫切需要，生物技術和製藥公司正在努力改進克隆過程。這些因素正在推動市場成長，預計在預測期內將出現指數級成長。

此外，預計細胞製備技術的進步將進一步推動對感受態細胞的需求。感受態細胞製備和轉化效率的技術進步對感受態細胞的性能和可靠性產生了重大影響，導致研究人員和工業用戶的需求不斷增加。此外，基因修飾和壓力反應途徑的開發進一步提高了轉化的可實現性，提供了針對特定應用的解決方案，並提高了勝任細胞在各個領域的效用。預計這些因素將在預測期內推動市場成長。

然而，生產和維護高效勝任細胞的高成本可能會限制其使用，特別是對於預算有限的小型研究機構和新興企業而言。預計這將影響勝任細胞在某些市場的採用率。此外，製備勝任細胞並成功轉化它們的過程在技術上可能很複雜，並且需要專門的知識和設備。因此，它將阻礙預測期內的市場成長。

勝任細胞市場報告亮點

  • 化學勝任細胞廣泛應用於重組DNA技術和分子生物學領域，2023年佔最大市場佔有率，為43.62%。另一方面，預計電感受態細胞在預測期內將以最快的複合年成長率成長。
  • 克隆細分市場預計將在 2023 年佔據應用細分市場佔有率。然而，由於各種工業和學術應用所需的重組蛋白和酶的需求不斷成長，預計蛋白質表達領域在預測期內將以 9.04% 的複合年成長率成長最快。
  • 由於藥物發現和藥物開發對感受態細胞的需求不斷成長，以及滿足監管標準所需的多項定性測試，製藥和生物技術公司細分市場將在 2023 年佔據最大佔有率。
  • 由於生物技術、醫學和治療學的強大研發以及政府的大量資助等因素，北美地區以 34.13% 的佔有率佔據市場主導地位。預計亞太地區在預測期內將以最快的複合年成長率成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章勝任細胞市場變因、趨勢、範圍

  • 市場體系展望
    • 母市場展望
    • 相關/補充市場展望。
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 勝任細胞市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章勝任細胞市場：按類型估計和趨勢分析

  • 細分儀表板
  • 全球勝任細胞市場：類型變異分析
  • 2018-2030年全球勝任細胞市場規模及趨勢分析（按類型）
  • 化學勝任細胞
  • 勝任細胞
  • 超勝任細胞

第5章勝任細胞市場：依應用估算與趨勢分析

  • 細分儀表板
  • 全球勝任細胞市場：應用變化分析
  • 2018-2030 年全球勝任細胞市場規模與趨勢分析（按應用）
  • 複製
  • 蛋白質表現
  • 誘變
  • 其他

第6章勝任細胞市場：最終用途的估計與趨勢分析

  • 細分儀表板
  • 全球勝任細胞市場：最終用途變化分析
  • 2018-2030 年全球勝任細胞市場規模與趨勢分析（依最終用途）
  • 製藥和生物技術公司
  • 學術研究所
  • 其他

第7章勝任細胞市場：區域估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 2018-2030年北美市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018年至2030年歐洲市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 2018-2030 年亞太市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市場估計與預測
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018年至2030年中東和非洲市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 公司/競爭對手分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介/上市公司
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Agilent Technologies, Inc.
    • Takara Bio Inc.
    • New England Biolabs（UK）Ltd.
    • Promega Corporation
    • Bio-Rad Laboratories
    • Roche Applied Science
    • Qiagen
    • SGI-DNA（Synthetic Genomics, Inc.）
Product Code: GVR-4-68040-310-3

Competent Cells Market Growth & Trends:

The global competent cells market size is anticipated to reach USD 3.59 billion by 2030, exhibiting a CAGR of 8.10% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing biopharmaceutical research, advancements in gene editing technologies, and the expanding field of synthetic biology is expected to propel market growth. Moreover, the biotechnology and pharmaceutical industries depend heavily on competent cells for the production of recombinant proteins, enzymes, and vaccines. The growing need for these products in medical treatments, research, and industrial applications fuels the demand for competent cells.

The COVID-19 pandemic has significantly boosted the market for competent cells, as companies increased their research and development efforts to address immediate health and scientific challenges. Competent cells, vital for tasks like molecular cloning, genetic engineering, and making recombinant proteins, have been in higher demand due to their key role in creating vaccines, diagnostic tests, and therapeutic research. The urgent need for vaccine manufacturing and treatments for COVID-19 has driven biotech and pharmaceutical companies to improve their cloning processes. These factors have impelled the growth of the market and are anticipated to propel exponentially over the forecast period.

In addition, technological advancements in cell preparation are projected to further propel the demand for competent cells. Technological advancements in the preparation and transformation efficiency of competent cells have significantly impacted the performance and reliability of competent cells, thus increasing the demand for researchers and industrial users. Additionally, genetic modifications and stress response pathway developments have further boosted transformation accomplishment, providing tailored solutions for specific applications, and advancing the utility of competent cells in various fields. These factors are thus projected to impel the growth of the market over the forecast period.

However, the high cost of producing and maintaining high-efficiency competent cells is considerable, which may limit their accessibility, especially for smaller research institutions and startups with limited budgets. This is anticipated to affect the adoption rate of competent cells in certain markets. Moreover, the process of preparing competent cells and accomplishing successful transformations could be technically complex and involve specialized knowledge and equipment. Thereby, hampering the growth of the market over the forecast period.

Competent Cells Market Report Highlights:

  • The chemically competent cells segment held the largest market share of 43.62% in 2023 due to their wide use in the field of recombinant DNA technology, and molecular biology. On the other hand, electrocompetent cells are anticipated to grow at the fastest CAGR over the forecast period.
  • In 2023, the cloning segment is anticipated to dominate the market share for the application segment. However, the protein expression segment is expected to grow at the fastest CAGR of 9.04% over the forecast period driven by the increasing demand for recombinant proteins and enzymes required in various industrial and academic applications.
  • The pharmaceutical & biotechnology companies segment dominated the end-use segment with the largest share in 2023 due to the rising demand for competent cells for drug discovery and development, along with the few qualitative tests required to fulfill the regulatory standards.
  • The North America region dominated the market with a share of 34.13% owing to factors such as strong R&D in biotechnology, medicine, and therapeutics, along with substantial government funding. Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Competent Cells Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing demand for recombinant proteins and antibodies
      • 3.2.1.2. Growing biotechnology and pharmaceutical industries
      • 3.2.1.3. Increasing research and development activities
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Costs of Competent Cells
  • 3.3. Competent Cells Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Competent Cells Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Competent Cells Market Type Movement Analysis
  • 4.3. Global Competent Cells Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Chemically Competent Cells
    • 4.4.1. Chemically competent cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Electrocompetent Cells
    • 4.5.1. Electrocompetent cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Ultracompetent Cells
    • 4.6.1. Ultracompetent cells market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Competent Cells Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Competent Cells Market Application Movement Analysis
  • 5.3. Global Competent Cells Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Cloning
    • 5.4.1. Cloning market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Protein Expression
    • 5.5.1. Protein expression market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Mutagenesis
    • 5.6.1. Mutagenesis market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competent Cells Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Competent Cells Market End-use Movement Analysis
  • 6.3. Global Competent Cells Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competent Cells Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.9. Denmark
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Regulatory framework
      • 7.5.9.3. Competitive scenario
      • 7.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Regulatory framework
      • 7.8.5.3. Competitive scenario
      • 7.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Agilent Technologies, Inc.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Takara Bio Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. New England Biolabs (UK) Ltd.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Promega Corporation
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Bio-Rad Laboratories
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Roche Applied Science
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Qiagen
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. SGI-DNA (Synthetic Genomics, Inc.)
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global competent cells market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 North America competent cells market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Mexico competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 17 Mexico competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Europe competent cells market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Germany competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 UK competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 27 UK competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 France competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 30 France competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 31 France competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Italy competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Spain competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Denmark competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Sweden competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 42 Sweden competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Norway competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 45 Norway competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific competent cells market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 China competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 52 China competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 53 China competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Japan competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 55 Japan competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 India competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 58 India competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 59 India competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 South Korea competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Australia competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 64 Australia competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Thailand competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 67 Thailand competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Latin America competent cells market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 71 Latin America competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Brazil competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 74 Brazil competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 Argentina competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 MEA competent cells market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 81 MEA competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 82 MEA competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 South Africa competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 84 South Africa competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 89 UAE competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 90 UAE competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait competent cells market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Competent cells market: Market outlook
  • Fig. 5 Competent cells market: Segment outlook
  • Fig. 6 Competent cells market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Competent cells market driver impact
  • Fig. 9 Competent cells market restraint impact
  • Fig. 10 Competent cells market: Type outlook and key takeaways
  • Fig. 11 Competent cells market: Type movement analysis
  • Fig. 12 Chemically competent cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Electrocompetent cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Ultracompetent cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Competent cells market: Application outlook and key takeaways
  • Fig. 16 Competent cells market: Application movement analysis
  • Fig. 17 Cloning market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Mutagenesis market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 20 Others market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 21 Competent cells market: End-use outlook and key takeaways
  • Fig. 22 Competent cells market: End-use movement analysis
  • Fig. 23 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 24 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Global competent cells market: Regional outlook and key takeaways
  • Fig. 27 Global competent cells market: Regional movement analysis
  • Fig. 28 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)